Cargando…
Efficacy of esomeprazole in treating acid-related diseases in Japanese populations
Esomeprazole (Nexium(®); AstraZeneca), the S-isomer of omeprazole, is the first proton pump inhibitor (PPI) to be developed as an optical isomer. Compared with omeprazole, esomeprazole has an improved pharmacokinetic profile with regards to CYP2C19 (S-mephenytoin 4′-hydroxylase) genotype, showing in...
Autores principales: | Sugimoto, Mitsushige, Furuta, Takahisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359912/ https://www.ncbi.nlm.nih.gov/pubmed/22649281 http://dx.doi.org/10.2147/CEG.S23926 |
Ejemplares similares
-
Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison
por: Furuta, Kenji, et al.
Publicado: (2014) -
Proton Pump Inhibitor Therapy before and after Endoscopic Submucosal Dissection: A Review
por: Sugimoto, Mitsushige, et al.
Publicado: (2012) -
Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer
por: Sugimoto, Mitsushige, et al.
Publicado: (2017) -
Risk of Reflux-Related Symptoms and Reflux Esophagitis after Helicobacter pylori Eradication Treatment in the Japanese Population
por: Sugimoto, Mitsushige, et al.
Publicado: (2021) -
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
por: Kalaitzakis, Evangelos, et al.
Publicado: (2007)